logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10828352 B1

PDFFull Text
Date of Patent:
Nov. 10, 2020

Filed:

Oct. 27, 2015

Compositions and methods for boosting the efficacy of adoptive cellular immunotherapy

Applicant:

Fred Hutchinson Cancer Research Center, Seattle, WA (US);

Inventors:

Susanna Carolina Berger, Seattle, WA (US);

Stanley R. Riddell, Sammamish, WA (US);

Assignee:

Fred Hutchinson Cancer Research Center, Seattle, WA (US);

Attorney:

Seed IP Law Group LLP

Primary Examiner:

Zachary S Skelding

Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07K 14/725 (2006.01); A61K 39/12 (2006.01); A61K 35/17 (2015.01); A61K 35/15 (2015.01); A61K 45/06 (2006.01); C07K 14/705 (2006.01); C07K 16/30 (2006.01); C07K 16/28 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 35/15 (2013.01); A61K 35/17 (2013.01); A61K 39/00111 (2018.08); A61K 39/00117 (2018.08); A61K 39/001103 (2018.08); A61K 39/001104 (2018.08); A61K 39/001106 (2018.08); A61K 39/001112 (2018.08); A61K 39/001113 (2018.08); A61K 39/001117 (2018.08); A61K 39/001122 (2018.08); A61K 39/001124 (2018.08); A61K 39/001129 (2018.08); A61K 39/001153 (2018.08); A61K 39/001156 (2018.08); A61K 39/001157 (2018.08); A61K 39/001168 (2018.08); A61K 39/001171 (2018.08); A61K 39/001181 (2018.08); A61K 39/001182 (2018.08); A61K 39/001186 (2018.08); A61K 39/001188 (2018.08); A61K 39/001195 (2018.08); A61K 39/12 (2013.01); A61K 45/06 (2013.01); C07K 14/7051 (2013.01); C07K 14/70578 (2013.01); C07K 16/30 (2013.01); A61K 48/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5156 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/57 (2013.01); C07K 16/2803 (2013.01); C07K 2317/622 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/33 (2013.01);
Abstract

The present disclosure provides compositions and methods for boosting, augmenting or enhancing the efficacy of the adoptive cellular immunotherapy by using modified T cells expressing an antigen binding protein in conjunction with modified cells (such as hematopoietic progenitor cells, modified human immune system cells or a combination thereof) expressing the antigen specifically bound by the antigen binding protein of the modified T cells.

Find Patent Forward Citations

Quick Actions:

Berger, Susanna. (2020). Compositions and methods for boosting the efficacy of adoptive cellular immunotherapy (U.S. Patent No. 10828352). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10828352

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…